Camilo E. Fadul MD

Neurology•Charlottesville, VA

Neurooncology

Professor, Neurology, University of Virginia

Join to View Full Profile

1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-244-7526

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 1992 - 1994
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1985 - 1987
Colegio Mayor de Nuestra Señora del RosarioClass of 1980

Certifications & Licensure

NH State Medical License 1995 - Present
VA State Medical License 2015 - 2026
VT State Medical License 1994 - 2014
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Combination Chemotherapy for Patients With Brain Cancer Start of enrollment: 1996 Aug 01
Completed
Phase 2
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme Start of enrollment: 1997 Mar 01
Completed
Phase 1
Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy Start of enrollment: 2002 Mar 01
Completed
Phase 2
Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 May 01
Completed
Phase 2
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Start of enrollment: 2008 Sep 01
Completed
Phase 2
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) Start of enrollment: 2010 Mar 01
Completed
Early Phase 1
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
Completed
Phase 1, Phase 2
Derivation of Tumor Specific Hybridomas Start of enrollment: 2014 Jan 01
Terminated
Phase 1
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 Jun 19
TERMINATED
PHASE2
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas Start of enrollment: 2013 Oct 09
RECRUITING
Phase I EGFR BATs in Newly Diagnosed Glioblastoma Start of enrollment: 2018 Mar 01
COMPLETED
PHASE1
BATs in Patients With Breast Cancer and Leptomeningeal Metastases Start of enrollment: 2019 Feb 26
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review.
Mark Willy L Mondia, Prem P Batchala, Robert Dreicer, Michael E Devitt, Matthew R McCord
The Prostate. 2025-03-13
Oesophageal adenocarcinoma presenting with synchronous brain metastases.
Derek Petrosian, Camilo E Fadul, Matthew Reilley, Patrick Dillon
BMJ Case Reports. 2025-01-31
Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.
Duy Q Pham, Darrah E Sheehan, Kimball A Sheehan, Konstantinos Katsos, Camilo E Fadul
Journal of Neuro-Oncology. 2025-01-01

Press Mentions

Indicators to Improve Multidisciplinary Care of Brain MetastasesSeptember 16th, 2024

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Academy of Neurology - AAN
Member
American Association for Cancer Research - AACR
Member
Society for Neuro-Oncology
Member